The New Jersey Devils lost 3:7 to the Pittsburgh Penguins in the NHL on Saturday.

Switzerland isn’t alone in facing supply problems. The United States, severely affected by avian flu since 2022, has seen egg ...

The bridge is currently being modified and, according to the latest information from Astra, is due to be used again in 2026. Merian says in future the bridge should also be useable on bends with a ...

According to the city of Basel's official website, the cortége features groups, also called cliques, who adhere to a "sujet," ...

公司动态 经济观察网讯 近日，国家药品监督管理局通过优先审评审批程序批准Roche Pharma (Schweiz) ...

Switzerland has some of the most spectacular views in the whole of Europe, but even the best photos and most detailed ...

airBaltic (BT, Riga) is expected to launch its initial public offering (IPO) in the second quarter of 2025 and has selected ...

The firm's Italian distributor A.D.A. is beginning a four-hospital study in collaboration with the Italian Society for Clinical Microbiology to evaluate the system.

Donald Trump has offered white South Africans asylum in the U.S to protect them from discrimination, he says. A visit to Orania – a place where Black people are not allowed to settle.

伊那利塞片是中国首个且目前唯一获批的高选择性PI3Kα抑制剂，也是HR+乳腺癌治疗领域唯一一款获得中美双重突破性疗法认证的产品，其独特的双重作用机制填补了HR+/HER2-晚期乳腺癌患者精准治疗空白。国家药监局表示，该药上市为患者提供了新的治疗选择。

近日，国家药品监督管理局以优先审评程序批准了Roche Pharma（Schweiz）AG申报的1类创新药物——伊那利塞片（商品名：伊赫莱）的上市。这一新药与哌柏西利和氟维司群结合使用，为内分泌治疗耐药的局部晚期或转移性乳腺癌患者带来了新的治疗选择。尤其是针对那些在辅助内分泌治疗期间或之后发生复发，且伴随有PIK3CA突变、激素受体（HR）阳性以及人表皮生长因子受体2（HER2）阴性的成人患者，伊 ...